AMLX logo

Amylyx Pharmaceuticals (AMLX)

Profile

Full Name

Amylyx Pharmaceuticals, Inc.

Ticker Symbol

AMLX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 7, 2022

Indexes

Not included

Website

http://amylyx.com

Employees

123

Key Details

Price

$6.33(-2.62%)

Market cap

$564.26M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$87.37M(-77.06% YoY)

Annual EPS

-$4.43(-732.86% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.33
    AMLX price is $6.33

    30-Day Relative Volume

    8.20
    AMLX 30-day relative volume is 8.20

    Price Performance

    Price Most recent change

    -2.62%
    AMLX price was down -2.62% on Jun 27, 2025

    Price YTD change

    +67.46%
    AMLX price is up +67.46% since January 1st

    Price 1-year change

    +233.16%
    AMLX price is up +233.16% year-on-year

    Price 3-year change

    -67.13%
    AMLX price is down -67.13% over the past 3 years

    Price Range

    Price All-time high

    $41.93
    AMLX price is currently -84.90% below its historical high of $41.93

    Price 3-year low

    $1.57
    AMLX price is currently +301.90% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $564.26M
    AMLX market capitalization is $564.26 million

    Market cap 3-year change

    -49.95%
    AMLX market capitalization is down -49.95% over the past 3 years

    Market cap All-time high

    $2.73B
    AMLX market capitalization is currently -79.36% below its historical high of $2.73 billion

    Market cap sector rank

    69.07%
    AMLX market capitalization is higher than 69.07% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +31.08%
    AMLX shares outstanding is up +31.08% year-on-year

    Shares Outstanding 3-Year Change

    +52.29%
    AMLX shares outstanding is up +52.29% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.17
    AMLX beta is 1.17

    200-day SMA

    $4.27
    AMLX price is currently +48.39% above its 200-day simple moving average

    50-day SMA

    $5.12
    AMLX price is currently +23.68% above its 50-day simple moving average

    RSI

    64.85
    AMLX 14-day relative strength index is 64.85

    Volume

    8.20
    AMLX 30-day relative volume is 8.20

    ATR

    $0.44
    AMLX average true range is $0.44

    10-day Historical Volatility

    148.76%
    AMLX 10-day historical volatility is 148.76%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $87.37M
    AMLX annual revenue is $87.37 million

    Revenue Analysts estimate

    -
    AMLX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -77.06%
    AMLX annual revenue is down -77.06% year-on-year

    Revenue Sector rank

    54.98%
    AMLX annual revenue is higher than 54.98% of companies in Healthcare sector

    EPS

    EPS

    -$4.43
    AMLX annual earnings per share is -$4.43

    EPS Analysts estimate

    -$1.88
    AMLX annual earnings per share is currently +135.89% higher than the consensus analysts' forecast

    EPS 1-year change

    -732.86%
    AMLX annual earnings per share is down -732.86% year-on-year

    EPS Sector rank

    21.65%
    AMLX annual earnings per share is higher than 21.65% of companies in Healthcare sector

    Profit

    Gross profit

    -$37.26M
    AMLX annual gross profit is -$37.26 million

    Gross margin

    -42.65%
    AMLX annual gross profit margin is -42.65%

    Operating profit

    -$291.88M
    AMLX annual operating income is -$291.88 million

    Operating margin

    -334.07%
    AMLX annual operating profit margin is -334.07%

    Net income

    -$301.74M
    AMLX annual net profit is -$301.74 million

    Net margin

    -345.36%
    AMLX annual net profit margin is -345.36%

    Expenses

    Total expenses

    $379.25M
    AMLX annual total expenses is $379.25 million

    Operating expenses

    $254.62M
    AMLX annual total operating expenses is $254.62 million

    Cost of goods sold

    $124.63M
    AMLX annual cost of goods sold is $124.63 million

    Selling, general & administrative expenses

    $114.33M
    AMLX annual SGA is $114.33 million

    Depreciation and amortization

    $904.00K
    AMLX annual depreciation & amortization is $904.00 thousand

    Interest expense

    -
    AMLX annual interest expense value is unknown

    Income tax

    -$393.00K
    AMLX annual income tax is -$393.00 thousand

    EBIT & EBITDA

    EBIT

    -$291.88M
    AMLX annual earnings before interest & taxes is -$291.88 million

    EBITDA

    -$290.98M
    AMLX annual EBITDA is -$290.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $193.63M
    AMLX annual total assets is $193.63 million

    Non current assets

    $4.20M
    AMLX annual long term assets is $4.20 million

    Current assets

    $189.43M
    AMLX annual total current assets is $189.43 million

    Cash and cash equivalents

    $77.39M
    AMLX annual cash & cash equivalents is $77.39 million

    Accounts receivable

    $447.00K
    AMLX annual accounts receivable is $447.00 thousand

    Inventory

    $0.00
    AMLX annual inventory is $0.00

    Liabilities

    Total liabilities

    $28.87M
    AMLX annual total liabilities is $28.87 million

    Long term liabilities

    $463.00K
    AMLX annual total long term liabilities is $463.00 thousand

    Current liabilities

    $28.41M
    AMLX annual total current liabilities is $28.41 million

    Accounts payable

    $2.94M
    AMLX annual accounts payable is $2.94 million

    Debt

    Total debt

    $1.98M
    AMLX annual total debt is $1.98 million

    Total debt 1-year change

    -53.25%
    AMLX annual total debt is down -53.25% year-on-year

    Long term debt

    $463.00K
    AMLX annual long term debt is $463.00 thousand

    Short term debt

    $1.52M
    AMLX annual short term debt is $1.52 million

    Equity & Capital

    Shareholders equity

    $164.76M
    AMLX annual stockholders equity is $164.76 million

    Book value

    $164.76M
    AMLX annual book value is $164.76 million

    Retained earnings

    -$606.69M
    AMLX annual retained earnings is -$606.69 million

    Working capital

    $161.03M
    AMLX annual working capital is $161.03 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$167.65M
    AMLX annual cash flow from operations is -$167.65 million

    Cash from operations 1-year change

    -1506.55%
    AMLX annual cash flow from operations is down -1506.55% year-on-year

    Cash from investing

    $75.65M
    AMLX annual cash flow from investing activities is $75.65 million

    Cash from investing 1-year change

    -17.81%
    AMLX annual cash flow from investing activities is down -17.81% year-on-year

    Cash from financing

    $348.00K
    AMLX annual cash flow from financing activities is $348.00 thousand

    Cash from financing 1-year change

    -90.18%
    AMLX annual cash flow from financing activities is down -90.18% year-on-year

    CAPEX

    CAPEX

    $157.00K
    AMLX annual capital expenditures is $157.00 thousand

    CAPEX 1-year change

    -87.35%
    AMLX annual capital expenditures is down -87.35% year-on-year

    Free Cash Flow

    Free cash flow

    -$167.80M
    AMLX annual free cash flow is -$167.80 million

    Free cash flow 1-year change

    -1671.49%
    AMLX annual free cash flow is down -1671.49% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -42.65%
    AMLX annual gross profit margin is -42.65%

    Operating margin

    -334.07%
    AMLX annual operating profit margin is -334.07%

    Net margin

    -345.36%
    AMLX annual net profit margin is -345.36%

    ROA & ROE

    ROA

    -84.87%
    AMLX annual return on assets is -84.87%

    ROE

    -100.88%
    AMLX annual return on equity is -100.88%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AMLX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AMLX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.80
    AMLX price to book ratio is 2.80

    PB ratio Sector rank

    66.75%
    AMLX price to book ratio is higher than 66.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    AMLX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AMLX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $505.88M
    AMLX enterprise value is $505.88 million

    Enterprise value Sector rank

    66.94%
    AMLX enterprise value is higher than 66.94% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.45
    AMLX EV/EBITDA is -2.45

    EV/EBITDA Sector rank

    34.99%
    AMLX EV/EBITDA is higher than 34.99% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.67
    AMLX annual current ratio is 6.67

    Quick ratio

    6.67
    AMLX annual quick ratio is 6.67

    Leverage

    Debt to equity

    0.00
    AMLX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    AMLX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    AMLX piotroski f-score value is unknown

    Altman Z-Score

    3.82
    AMLX altman z-score is 3.82

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 Citigroup
    Buy
    May 14, 25 Mizuho
    Outperform
    May 9, 25 HC Wainwright & Co.
    Buy
    May 7, 25 Leerink Partners
    Outperform
    Apr 7, 25 Mizuho
    Outperform
    Mar 5, 25 HC Wainwright & Co.
    Buy
    Dec 5, 24 HC Wainwright & Co.
    Buy
    Nov 18, 24 Baird
    Outperform
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Oct 18, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AMLX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Amylyx Pharmaceuticals?
    • Does Amylyx Pharmaceuticals pay dividends?
    • What sector is Amylyx Pharmaceuticals in?
    • What industry is Amylyx Pharmaceuticals in?
    • What country is Amylyx Pharmaceuticals based in?
    • When did Amylyx Pharmaceuticals go public?
    • Is Amylyx Pharmaceuticals in the S&P 500?
    • Is Amylyx Pharmaceuticals in the NASDAQ 100?
    • Is Amylyx Pharmaceuticals in the Dow Jones?
    • When was Amylyx Pharmaceuticals's last earnings report?
    • When does Amylyx Pharmaceuticals report earnings?
    • Should I buy Amylyx Pharmaceuticals stock now?

    What is the ticker symbol for Amylyx Pharmaceuticals?

    The ticker symbol for Amylyx Pharmaceuticals is NASDAQ:AMLX

    Does Amylyx Pharmaceuticals pay dividends?

    No, Amylyx Pharmaceuticals does not pay dividends

    What sector is Amylyx Pharmaceuticals in?

    Amylyx Pharmaceuticals is in the Healthcare sector

    What industry is Amylyx Pharmaceuticals in?

    Amylyx Pharmaceuticals is in the Biotechnology industry

    What country is Amylyx Pharmaceuticals based in?

    Amylyx Pharmaceuticals is headquartered in United States

    When did Amylyx Pharmaceuticals go public?

    Amylyx Pharmaceuticals's initial public offering (IPO) was on January 7, 2022

    Is Amylyx Pharmaceuticals in the S&P 500?

    No, Amylyx Pharmaceuticals is not included in the S&P 500 index

    Is Amylyx Pharmaceuticals in the NASDAQ 100?

    No, Amylyx Pharmaceuticals is not included in the NASDAQ 100 index

    Is Amylyx Pharmaceuticals in the Dow Jones?

    No, Amylyx Pharmaceuticals is not included in the Dow Jones index

    When was Amylyx Pharmaceuticals's last earnings report?

    Amylyx Pharmaceuticals's most recent earnings report was on May 8, 2025

    When does Amylyx Pharmaceuticals report earnings?

    The next expected earnings date for Amylyx Pharmaceuticals is Nov 7, 2025

    Should I buy Amylyx Pharmaceuticals stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page